Researchers investigate how synaptic pruning occurs during development in hopes of discovering how neurodevelopmental and psychiatric disorders occur.
Researchers look at how sleep deprivation can impact cognition, information processing and memory. A new study reveals sleep deprived mice can demonstrate sleep like brain activity while awake.
Patients with schizophrenia who are prescribed cannabidiol (CBD) in
addition to antipsychotics may experience lower levels of positive
psychotic symptoms compared with those taking antipsychotics
alone, according to a report in AJP in Advance.
Patients who have experienced first-episode psychosis (FEP)
appear to have significantly lower levels of folate and
vitamin D in their blood compared with individuals with no
psychiatric diagnosis, according to a report in Schizophrenia
The number of prescriptions of antidepressants for children
and adolescents fell after the Food and Drug Administration
in 2004 directed pharmaceutical companies to issue a blackbox
warning about the potential link between antidepressant
use and the risk of increased suicidal ideation among youth.
A new study links the white matter integrity of the corpus callosum with a person’s likelihood of experiencing auditory hallucinations and their musical aptitude.
A major finding from researchers at Houston Methodist reveals a significant number of people diagnosed with schizophrenia or bipolar disorder may actually have a treatable immune system disorder. The condition causes NMDA receptors to stop functioning properly and can result in symptoms commonly associated with neuropsychiatric disorders.
Several new genome-wide investigations of schizophrenia and substance-use disorders are helping researchers understand how these two conditions may be related, according to a paper published in Genome Medicine.
New findings will help to identify the genetic causes of brain disorders: researchers at the Universities of Basel, Bonn and Cologne have presented a systematic catalog of specific variable locations in the genome that influence gene activity in the human hippocampus, as they report in the journal Nature Communications.
Summary: Using mini-brains grown in the lab, researchers have discovered schizophrenia likely begins toward the end of the first trimester of fetal development. Researchers believe, based on their findings, schizophrenia could potentially be treated in utero.